Hyundai Pharmaceutical Co., Ltd. (004310.KS)

KRW 3710.0

(-2.62%)

Total Liabilities Summary of Hyundai Pharmaceutical Co., Ltd.

  • Hyundai Pharmaceutical Co., Ltd.'s latest annual total liabilities in 2023 was 69.96 Billion KRW , down -26.04% from previous year.
  • Hyundai Pharmaceutical Co., Ltd.'s latest quarterly total liabilities in 2024 Q3 was 72.12 Billion KRW , down -5.32% from previous quarter.
  • Hyundai Pharmaceutical Co., Ltd. reported annual total liabilities of 94.6 Billion KRW in 2022, up 22.45% from previous year.
  • Hyundai Pharmaceutical Co., Ltd. reported annual total liabilities of 77.25 Billion KRW in 2021, up 14.69% from previous year.
  • Hyundai Pharmaceutical Co., Ltd. reported quarterly total liabilities of 72.12 Billion KRW for 2024 Q3, down -5.32% from previous quarter.
  • Hyundai Pharmaceutical Co., Ltd. reported quarterly total liabilities of 76.17 Billion KRW for 2024 Q2, up 4.54% from previous quarter.

Annual Total Liabilities Chart of Hyundai Pharmaceutical Co., Ltd. (2023 - 2007)

Historical Annual Total Liabilities of Hyundai Pharmaceutical Co., Ltd. (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 69.96 Billion KRW -26.04%
2022 94.6 Billion KRW 22.45%
2021 77.25 Billion KRW 14.69%
2020 67.36 Billion KRW 6.94%
2019 62.99 Billion KRW 8.64%
2018 57.98 Billion KRW 2.59%
2017 56.51 Billion KRW 11.99%
2016 50.46 Billion KRW 19.85%
2015 42.1 Billion KRW -1.18%
2014 42.6 Billion KRW 0.99%
2013 42.19 Billion KRW -15.98%
2012 50.21 Billion KRW 25.47%
2011 40.02 Billion KRW 4.02%
2010 38.47 Billion KRW -7.66%
2009 41.66 Billion KRW 9.45%
2008 38.07 Billion KRW 82.74%
2007 20.83 Billion KRW 0.0%

Peer Total Liabilities Comparison of Hyundai Pharmaceutical Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Yuyu Pharma, Inc. 77.85 Billion KRW 10.134%
Dong-A Socio Holdings Co., Ltd. 929.79 Billion KRW 92.475%
Ildong Holdings Co., Ltd. 707.09 Billion KRW 90.105%
HANDOK Inc. 449.7 Billion KRW 84.441%
Kukje Pharma Co., Ltd. 85.67 Billion KRW 18.329%
Yuhan Corporation 712.33 Billion KRW 90.178%
Dong-A ST Co., Ltd. 631.91 Billion KRW 88.928%
SAMSUNG PHARM. Co., LTD. 15.89 Billion KRW -340.201%
Hanmi Pharm. Co., Ltd. 851.82 Billion KRW 91.786%
Hanall Biopharma Co.,Ltd 53.52 Billion KRW -30.711%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW 66.015%
Dong Sung Bio Pharm.Co.,Ltd. 75.17 Billion KRW 6.922%
MYUNGMOON Pharm co.,Ltd 147.79 Billion KRW 52.659%
Hana Pharm Co., Ltd. 70.4 Billion KRW 0.616%
Yuyu Pharma, Inc. 77.85 Billion KRW 10.134%
Ilsung Pharmaceuticals Co., Ltd. 36.43 Billion KRW -92.028%
REYON Pharmaceutical Co., Ltd. 251.15 Billion KRW 72.141%
Aprogen pharmaceuticals,Inc. 220.7 Billion KRW 68.298%
JW Holdings Corporation 827.51 Billion KRW 91.545%
Ildong Pharmaceutical Co., Ltd. 436.99 Billion KRW 83.989%
Chong Kun Dang Pharmaceutical Corp. 586.79 Billion KRW 88.076%
JW Pharmaceutical Corporation 379.59 Billion KRW 81.568%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW 11.77%
Samil Pharmaceutical Co.,Ltd 242.85 Billion KRW 71.189%
Jeil Pharmaceutical Co.,Ltd 330.29 Billion KRW 78.817%
Yuyu Pharma, Inc. 77.85 Billion KRW 10.134%
Kwang Dong Pharmaceutical Co., Ltd. 490.01 Billion KRW 85.721%
Daewoong pharmaceutical Co.,Ltd 858.02 Billion KRW 91.846%
JW Pharmaceutical Corporation 379.59 Billion KRW 81.568%
Yuhan Corporation 712.33 Billion KRW 90.178%
Jeil Pharma Holdings Inc 477.81 Billion KRW 85.357%
Yungjin Pharm. Co., Ltd. 136.96 Billion KRW 48.917%
Suheung Co., Ltd. 516.66 Billion KRW 86.458%
JW Pharmaceutical Corporation 379.59 Billion KRW 81.568%
Samjin Pharmaceuticals Co., Ltd. 154.53 Billion KRW 54.724%
Korea United Pharm Inc. 89.96 Billion KRW 22.228%
CKD Bio Corp. 170.76 Billion KRW 59.026%
Daewon Pharmaceutical Co., Ltd. 243.73 Billion KRW 71.293%
Dongwha Pharm.Co.,Ltd 157.65 Billion KRW 55.62%
Whan In Pharm Co.,Ltd. 43.01 Billion KRW -62.643%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW 11.77%
Chong Kun Dang Holdings Corp. 632.51 Billion KRW 88.938%
Boryung Corporation 373.1 Billion KRW 81.247%
Bukwang Pharmaceutical Co., Ltd. 208.19 Billion KRW 66.394%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW 66.015%
JW Lifescience Corporation 96.44 Billion KRW 27.452%